Manufacturer record
Unicure India Ltd. C-21: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Unicure India Ltd. C-21 (Uttar Pradesh) were declared Not of Standard Quality between August 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ATBC1301, Ampicillin Capusules IP 500mg (exp Oct 2027). SDTL, Guwahati (state lab) found it not of standard quality: The sample does not conform to IP with respect to the Dissolution. Listed in the September 2026 alert.
Records by type
8 records linked to Unicure India Ltd. C-21 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ampicillin Capusules IP 500mg | Batch ATBC1301Mfg Nov 2025 · Exp Oct 2027 | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab | Sep 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg. | Batch ANET1295Mfg Dec 2024 · Exp Nov 2026 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution in Acid stage for Aspirin.Dissolution | RDTL, GuwahatiCDSCO lab | Feb 2026 |
| Paracetamol Tablets IP 500mg | Batch PCT1211Mfg Aug 2024 · Exp Jul 2026 | The sample does not confirm to IP2022 requirement withespect to Dissolution TestDissolution | DTL,Dalgate Srinagar Kashmir( J and K)State lab | Jan 2026 |
| Vildagliptin and Metformin Tablets IP | Batch VMHT1315Mfg May 2025 · Exp Apr 2027 | The sample received does not conform to I.P. 2022 with respect to Assay and Dissolution.Assay | CDTL, MumbaiCDSCO lab | Dec 2025 |
| Paracetamol Tablets I.P. (500 mg) | Batch PCT1210Mfg Aug 2024 · Exp Jul 2026 | The sample does not conform to I.P with respect to the test for Dissolution.Dissolution | CDTL, IndoreCDSCO lab | Oct 2025 |
| Norfloxacin Tablets IP 400 mg | Batch NT-802Mfg Oct 2020 · Exp Sep 2022 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jul 2021 |
| Norfloxacin Tablet I.P. 400 mg. | Batch NT603Mfg Feb 2019 · Exp Jan 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2019 |
| Norfloxacin Tablets I.P. 400 mg | Batch NT606Mfg Feb 2019 · Exp Jan 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.